Ritsuro Suzuki

スズキリツロウ | Ritsuro Suzuki

Affiliation and department：
Job title： Proffesser

Research field (1)： Hematology and oncology

Research keywords (3)：白血病 , 悪性リンパ腫 , 血液腫瘍

Research theme for competitive and other funds (18)：

2020 - 2023 国際共同によるNK/T細胞リンパ腫の病態比較と治療最適化
2017 - 2020 Optimization of new generation therapy for NK/T-cell lymphoma in East Asia
2016 - 2019 Differential diagnosis of Japanese patients with CLL and related disorders
2014 - 2017 NKEA project: Next-Generation Therapy for NK/T-cell lymphoma in East Asia
2009 - 2011 Establishment of outcome registry system for hematopoietic stem cell transplantation

Show all

Papers (321)：

Motoko Yamaguchi, Noriko Fukuhara, Jun Takizawa, Kenji Ishitsuka, Akihiko Yokohama, Kana Miyazaki, Yuma Nato, Satoshi Ichikawa, Masaki Mitobe, Kodai Shima, et al. Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan. Journal of clinical and experimental hematopathology : JCEH. 2024
Jun Takizawa, Ritsuro Suzuki, Koji Izutsu, Toru Kiguchi, Hideki Asaoku, Yoshio Saburi, Taro Masunari, Atae Utsunomiya, Kengo Takeuchi, Naoya Nakamura, et al. Characteristics of chronic lymphocytic leukemia in Japan: Comprehensive analysis of the CLLRSG-01 study. International Journal of Hematology. 2024. 119. 6. 686-696
Koji Kato, Takeshi Sugio, Takashi Ikeda, Kanako Yoshitsugu, Kana Miyazaki, Junji Suzumiya, Go Yamamoto, Sung-Won Kim, Kazuhiro Ikegame, Yasufumi Uehara, et al. Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma. Bone marrow transplantation. 2024. 59. 3. 306-314
Mizuki Watanabe, Junya Kanda, Takahiro Fukuda, Naoyuki Uchida, Kazuhiro Ikegame, Keisuke Kataoka, Hikaru Kobayashi, Takahide Ara, Jun Ishikawa, Ken-Ichi Matsuoka, et al. Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy. British journal of haematology. 2023. 203. 3. 446-459
Nobuaki Nakano, Hideki Nakasone, Shigeo Fuji, Akihito Shinohara, Ritsuro Suzuki, Atae Utsunomiya, Tetsuya Eto, Satoko Morishima, Kazuhiro Ikegame, Yasutaka Kakinoki, et al. Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey. The Lancet regional health. Western Pacific. 2023. 40. 100902-100902

ｍore...

MISC (216)：

Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, et al. Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study). BLOOD. 2022. 140. 11890-11892
Ayumi Fujimoto, Ritsuro Suzuki. Epstein-barr virus-associated post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation: Pathogenesis, risk factors and clinical outcomes. Cancers. 2020. 12. 2
山崎聡, 新田英昭, 新田英昭, 近藤英生, 内田直之, 宮崎拓也, 石川謙, 清田実希, 松岡広, 一戸辰夫, et al. Effect of allogeneic HCT for patients with T-prolymphocytic leukemia. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
島崎裕正, 三宅隆明, 伊藤俊輔, 井上政弥, 井上政弥, 高橋勉, 鈴木律朗, 尾崎司, 惣宇利正善, 一瀬白帝, et al. 治療抵抗性の自己免疫性第13因子欠乏症の1症例. 日本血栓止血学会誌. 2019. 30. 2. 435-435
Reiji Fukano, Naoto Fujita, Tetsuya Mori, Ryoji Kobayashi, Tetsuo Mitsui, Koji Kato, Ritsuro Suzuki, Junji Suzumiya, Takahiro Fukuda, Motohiro Shindo, et al. Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. 2018. 182. 34-34

ｍore...

Books (16)：

今日の治療指針 2018年版
医学書院 2018
インフォームドコンセントのための図説シリーズ:悪性リンパ腫
医薬ジャーナル社 2017
血液疾患最新の治療2017-2019
南江堂 2017
内科学第十一版
朝倉書店 2017
血液疾患最新の治療2017-2019
南江堂 2017

ｍore...

Lectures and oral presentations (102)：

A phase I fixed-dose feasibility study of MK615 and gemcitabine in patients with advanced or metastatic pancreatic cancer.
(2018 Gastrointestinal Cancer Symposium of the American Society of Clinical Oncology 2018)
Efficacy of once-daily intravenous busulfan in allogeneic transplantation: a matched-pair analysis.
(第40回日本造血細胞移植学会総会 2018)
同種造血幹細胞移植1年後に再発性多発軟骨炎類似の気管支狭窄症を発症し、気管支ステント留置で改善した一例
(第40回日本造血細胞移植学会総会 2018)
Efficacy of reduced-intensity conditioning for relapsed or refractory anaplastic large cell lymphoma.
(第40回日本造血細胞移植学会総会 2018)
当科での急性白血病患者における中心静脈と末梢留置型中心静脈カテーテルの比較
(第57回日本血液学会中国四国地方会 2018)

ｍore...

Education (1)：

- 1989 Nagoya University School of Medicine

Professional career (1)：

医学博士 (名古屋大学)

Work history (6)：

2020/11 - 現在 Shimane University Faculty of Medicine, Department of Hematology and Oncology Proffesser
2014/10 - 2020/10 Shimane University Cancer Center Associate Professor
2014/01 - 2014/09 Japanese Red Cross Nagoya Daini Hospital Department of Medical Oncology
2006/01 - 2013/12 Nagoya University School of Medicine Department of HSCT Data Management and Biostatistics Associate Professor
1997/01 - 2005/12 Aichi Cancer Center, Research Institute Department of Molecular Medicine Senior Researcher

Show all

Committee career (48)：

2018 - 2019 日本血液学会血液専門医テキスト編集委員
2017 - 2019 日本リンパ網内系学会診療・保険委員アドバイザー
2016 - 2019 日本癌学会評議員
2014 - 2019 日本医学会用語委員
2014 - 2019 日本造血細胞移植学会用語委員

Show all

Association Membership(s) (5)：

日本医学会 , 日本造血細胞移植学会 , 日本癌学会 , 日本リンパ網内系学会 , 日本血液学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page